ReNerve Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Julian Chick
Chief executive officer
AU$321.4k
Total compensation
| CEO salary percentage | 91.8% |
| CEO tenure | less than a year |
| CEO ownership | 9.9% |
| Management average tenure | no data |
| Board average tenure | 8.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -AU$3m |
| Jun 30 2023 | AU$321k | AU$295k | -AU$2m |
| Jun 30 2022 | AU$230k | AU$210k | -AU$2m |
Compensation vs Market: Julian's total compensation ($USD201.04K) is below average for companies of similar size in the Australian market ($USD291.73K).
Compensation vs Earnings: Julian's compensation has increased whilst the company is unprofitable.
CEO
Julian Chick (55 yo)
less than a year
Tenure
AU$321,439
Compensation
Dr. Julian John Chick, BSc (Hons), Ph. D. (La Trobe), serves as an Executive Director at RENERVE LIMITED since September 16, 2016 and serves its Chief Executive Officer since October 11, 2024. He serves as...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 8.3yrs | AU$321.44k | 9.86% A$ 2.0m | |
| CSO & Executive Director | 8.3yrs | AU$264.87k | 8.13% A$ 1.7m | |
| Chief Medical Officer & Member of Scientific Advisory Board | no data | no data | 3.46% A$ 711.9k | |
| Independent Non-Executive Director | 6.7yrs | no data | 2.51% A$ 516.5k | |
| Independent Chairman | 8.3yrs | no data | 7.37% A$ 1.5m | |
| Member of the Scientific Advisory Board | no data | no data | no data |
8.3yrs
Average Tenure
Experienced Board: RNV's board of directors are considered experienced (8.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 22:19 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ReNerve Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|